The DDIT4L-TOM40-ATP5A pathway suppresses glioblastoma oncogenesis
You, P.; Qi, Z.-X.; Luo, H.; Cai, B.; Hu, X.-Y.; Pan, J.; Gan, P.-P.; Zeng, X.-Y.; Liao, R.-J.; Tang, Q.-S.; Yu, Y.; Zhang, Z.-N.; Yang, B.-J.; Chen, L.; Zhang, X.; Li, K.-C.; Mao, Y.
Show abstract
The characteristics of glioblastoma (GBM), including resistance to cell death and aberrant energy metabolism, are associated with the function of mitochondria. To date, the inherent suppressors that couple mitochondrial function with cell death remain unclear. DNA damage-inducible transcript 4-like (DDIT4L) expression in human gliomas and its association with patient survival was determined by public databases, western-blot and immunostaining. The role of DDIT4L in regulating tumor growth was analyzed using lentivirus and PDX model. The mechanism of DDIT4L on GBM mitochondrial function was determined by different assays. Here, we show that DDIT4L is an endogenous inhibitor of GBM via suppressing mitochondrial function. DDIT4L was expressed at high levels in GBM and transported into mitochondria via single import channel TOM40 other than the import receptors TOM22, TOM20 or TOM70. Then, DDIT4L interacted with the subunit of ATP synthase, inhibited mitochondrial function and induced tumor cell apoptosis. Furthermore, the synthetic peptide DDIT4LV125-P132 suppressed GBM oncogenesis. Based on these results, DDIT4L suppresses GBM oncogenesis through both TOM40- and ATP5A-dependent mechanisms to curb mitochondrial dynamics and induce cell apoptosis, and the DDIT4LV125-P132 peptide is a potential therapy for GBM.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis 94%
- RAB12-LRRK2 Complex Suppresses Primary Ciliogenesis and Regulates Centrosome Homeostasis in Astrocytes 94%
- Purine metabolism regulates DNA repair and therapy resistance in glioblastoma 94%
Similar papers in this journal
- EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma 94%
- MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB) 93%
- Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells 93%
Similar papers in this journal
- Brain-derived exosomal hemoglobin transfer contributes to neuronal mitochondrial homeostasis under hypoxia 94%
- Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor 94%
- STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer 94%
Similar papers in this journal
- MEOX2 homeobox gene promotes growth of malignant gliomas 95%
- FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses 95%
- Pyruvate carboxylation identifies Glioblastoma Stem-like Cells opening new metabolic strategy to prevent tumor recurrence 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.